Sophiris Bio Inc. (SPHS) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sophiris Bio Inc.  (SPHS)


Sophiris Bio's ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sophiris Bio's ROI in the third quarter of 2019?
Sophiris Bio Inc. achieved a return on average invested assets (ROI) of 0.81 % in its third quarter of 2019, this is above SPHS's average return on investment of -76.75%.
Sophiris Bio Inc. invested over the 12 months ending in its third quarter of 2019 $5 million

ROI has improved compared to -28% in the second quarter of 2019, due to net income growth.

Within the Healthcare sector 191 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 0 to 2537.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Investment Change TTM -73.63 % -68.44 % -58.66 % -47.11 % -33.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 2 5 8 12
Return On Investment (TTM) 0.81 % -28 % -59.65 % -50.92 % -94.02 %
SPHS's Overall Ranking # 2537 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -31.92 % -31.19 % -26.84 % -23.05 % -18.54 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 -2 -6 -7 -16

SPHS Company Profile >> Back to SPHS Roi Comparisons >> See Annual SPHS Return On Investment



Return On Investment SPHS's Ranking
Within: No.
Industry # 63
Sector # 192
Overall # 2537

Return On Investment Statistics
High Average Low
58.4 %
-76.75 %
-226.52 %
(Sep 30 2014)   (Jun 30 2016)







Financial Statements
Sophiris Bio's III. Quarter Investments $ 3 Millions SPHS's Balance sheet
Sophiris Bio's III. Quarter Income $ -1 Millions Quarterly SPHS's Income Statement
SPHS's Income by Division See SPHS's Income by Division


SPHS Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 8 24 28 6 20
Y / Y Investment Growth -65.98 % -12.97 % 391.98 % -71.84 % -51.52 %
Net Income in Millions -7 -9 -11 -14 -31
Y / Y Net Income Growth - - - - -
Annual Return On Investment -82.41 % -35.69 % -40.19 % -251.45 % -153.15 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SPHS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SPHS's Competitors
Subscribers only: Roi for Sophiris Bio's Suppliers
Subscribers only: Return On Investment for SPHS's Customers

Other Ratios
SPHS's Roa SPHS's Inventory Turnover Ratio SPHS's Growth Rates SPHS's Dividend Statistics
SPHS's Profitability Ratios SPHS's Asset Turnover Ratio SPHS's Dividend Growth
SPHS's Roe SPHS's Valuation Ratios SPHS's Financial Strength Ratios SPHS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI
The Pennant Group Inc   2.21 %
Neurocrine Biosciences Inc   2.21 %
Dentsply Sirona Inc   2.12 %
Nature s Sunshine Products inc   2.00 %
Conmed Corporation  1.95 %
Integra Lifesciences Holdings Corp  1.84 %
Omnova Solutions Inc  1.81 %
Insulet Corporation  1.80 %
Labcorp Holdings Inc   1.47 %
Syneos Health Inc   1.47 %
Iqvia Holdings Inc   1.44 %
Merit Medical Systems Inc  1.23 %
Luminex Corporation  1.17 %
Elanco Animal Health Incorporated  1.15 %
Procyon Corporation  1.13 %
Avantor Inc   1.02 %
Enzo Biochem Inc  0.91 %
Sophiris Bio Inc.  0.81 %
Scienture Holdings Inc   0.80 %
Natus Medical Inc  0.75 %
American Renal Associates Holdings Inc   0.72 %
Tenet Healthcare Corp  0.65 %
National Vision Holdings Inc   0.61 %
Infusystem Holdings Inc  0.55 %
Magellan Health inc   0.34 %
Pacira Biosciences inc   0.32 %
Lannett Company Inc  0.32 %
Jrsis Health Care Corp  0.22 %
Emergent Biosolutions Inc   0.21 %
Lakeland Industries Inc   0.17 %

Date modified: 2026-09-26T07:05:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.